Advocacy and Public Policy
The Association of Community Cancer Centers champions the importance of access to cancer specialists and appropriate cancer therapies and leads efforts to respond to regulations and legislation that threaten to compromise the delivery of quality cancer care. On your behalf, ACCC works with the Centers for Medicare & Medicaid Services, the U.S. Government Accountability Office, the Medicare Payment Advisory Commission (MEDPAC), and other key policy makers in Washington, D.C., to ensure patient access to quality cancer care in community cancer programs and in physician offices.
ACCC serves as a policy advocate to its hospital members on federal legislative/regulatory issues and as an essential information resource on all Medicare reimbursement issues facing its hospital members.
ACCC continues to monitor, respond, and communicate to our physician practice members any changes in Medicare reimbursement to Part B covered drugs and biologicals, drug administration, and coding.
Medicare coverage policies and off-label issues continue to be a primary area of focus for ACCC. ACCC works to ensure patient access to new oncology drugs.
ACCC Urges the President and Congress to Oppose $3 Billion Cut to Medicare Reimbursement
On July 14, 2011, the Association of Community Cancer Centers (ACCC) joined with nine other groups in the oncology community to urge lawmakers to oppose a $3 billion funding cut to Medicare reimbursement for cancer drugs and biologics. The measure is proposed as part of the ongoing deficit-reduction and debt-ceiling discussions taking place between Congress and the White House.
ACCC's MyNetwork
Facebook
LinkedIn
Twitter
ACCC Vision Channel